579 related articles for article (PubMed ID: 14530392)
1. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
3. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
4. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
[TBL] [Abstract][Full Text] [Related]
5. Celiac disease--sandwiched between innate and adaptive immunity.
Stepniak D; Koning F
Hum Immunol; 2006 Jun; 67(6):460-8. PubMed ID: 16728270
[TBL] [Abstract][Full Text] [Related]
6. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
7. Equilibrium and kinetic analysis of the unusual binding behavior of a highly immunogenic gluten peptide to HLA-DQ2.
Xia J; Sollid LM; Khosla C
Biochemistry; 2005 Mar; 44(11):4442-9. PubMed ID: 15766274
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
9. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of celiac disease.
Koning F
J Mol Recognit; 2003; 16(5):333-6. PubMed ID: 14523946
[TBL] [Abstract][Full Text] [Related]
11. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.
Bodd M; Tollefsen S; Bergseng E; Lundin KE; Sollid LM
Hum Immunol; 2012 Apr; 73(4):376-81. PubMed ID: 22342873
[TBL] [Abstract][Full Text] [Related]
12. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: caught between a rock and a hard place.
Koning F
Gastroenterology; 2005 Oct; 129(4):1294-301. PubMed ID: 16230082
[TBL] [Abstract][Full Text] [Related]
15. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
Ráki M; Tollefsen S; Molberg Ø; Lundin KE; Sollid LM; Jahnsen FL
Gastroenterology; 2006 Aug; 131(2):428-38. PubMed ID: 16890596
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
Nielsen C; Husby S; Lillevang ST
Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
[TBL] [Abstract][Full Text] [Related]
18. Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease.
Kapoerchan VV; Wiesner M; Overhand M; van der Marel GA; Koning F; Overkleeft HS
Bioorg Med Chem; 2008 Feb; 16(4):2053-62. PubMed ID: 18037302
[TBL] [Abstract][Full Text] [Related]
19. Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer.
Kooy-Winkelaar Y; van Lummel M; Moustakas AK; Schweizer J; Mearin ML; Mulder CJ; Roep BO; Drijfhout JW; Papadopoulos GK; van Bergen J; Koning F
J Immunol; 2011 Nov; 187(10):5123-9. PubMed ID: 22013116
[TBL] [Abstract][Full Text] [Related]
20. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.
Fallang LE; Bergseng E; Hotta K; Berg-Larsen A; Kim CY; Sollid LM
Nat Immunol; 2009 Oct; 10(10):1096-101. PubMed ID: 19718029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
